1. Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer
    Shan-Shan Luo et al, 2018, BioMed Research International CrossRef
  2. Expression of ERCC1 and TYMS in colorectal cancer patients and the predictive value of chemotherapy efficacy
    Hong Jiang et al, 2019, Oncology Letters CrossRef
  3. Association of DNA Repair and Drug Transporter in Relation to Chemosensitivity in Primary Culture of Thai Gastric Cancer Patients
    Pattama Wongsirisin et al, 2018, Biological and Pharmaceutical Bulletin CrossRef
  4. The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
    Yali Cheng et al, 2021, Frontiers in Oncology CrossRef
  5. Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways
    Jie Chen et al, 2015, Archives of Biochemistry and Biophysics CrossRef
  6. Metallodrugs are unique: opportunities and challenges of discovery and development
    Elizabeth J. Anthony et al, 2020, Chemical Science CrossRef
  7. Effect of 5‐fluorouracil on excision repair cross‐complementing 1 expression and consequent cytotoxicity regulation in human gastric cancer cells
    Jing‐Lan Liu et al, 2018, Journal of Cellular Biochemistry CrossRef
  8. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
    Hong Lin et al, 2022, Molecular Cancer CrossRef
  9. XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
    Ming-Yii Huang et al, 2023, Cells CrossRef
  10. Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis
    Xueyong Liu et al, 2017, Oncotarget CrossRef
  11. Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy
    Sepideh Mirzaei et al, 2021, Life Sciences CrossRef
  12. siRNA-based therapy for gastric adenocarcinoma: what’s next step?
    Dyar Mudhafar Salman et al, 2024, Pathology - Research and Practice CrossRef